2020 Position Statement on Off-Label Use and Misuse of Testosterone, Growth Hormone, Thyroid Hormone, and Adrenal Supplements: Risks and Costs of a Growing Problem

Synthèse documentaire ASEM

Document officiel de American Association of Clinical Endocrinology (2020) sur « 2020 Position Statement on Off-Label Use and Misuse of Testosterone, Growth Hormone, Thyroid Hormone, and Adrenal Supplements: Risks and Costs of a Growing Problem ». Extrait officiel (langue source) : This position statement raises awareness about the risks of off-label use and misuse of testosterone, growth hormone, thyroid hormone, and adrenal supplements. This statement distinguishes off-label hormone use from legitimate use for diagnoses such as male hypogonadism, growth hormone deficiency, hypothyroidism, and adrenal insufficiency. DOI: 10.4158/PS-2019-0540. Consultez la publication officielle pour les recommandations détaillées et leur champ d’application.

Cette synthèse facilite le repérage du document. Pour les recommandations cliniques, consultez toujours la version officielle et sa date de mise à jour.